244 related articles for article (PubMed ID: 30341246)
41. Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer.
Fu DY; Tan HS; Wei JL; Zhu CR; Jiang JX; Zhu YX; Cai FL; Chong MH; Ren CL
Tumour Biol; 2015 Sep; 36(10):8025-34. PubMed ID: 25971583
[TBL] [Abstract][Full Text] [Related]
42. Expression and clinical implications of basic leucine zipper ATF-like transcription factor 2 in breast cancer.
Lin Y; Zhou X; Peng W; Wu J; Wu X; Chen Y; Cui Z
BMC Cancer; 2021 Sep; 21(1):1062. PubMed ID: 34565331
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA regulation of F-box proteins and its role in cancer.
Wu ZH; Pfeffer LM
Semin Cancer Biol; 2016 Feb; 36():80-7. PubMed ID: 26433073
[TBL] [Abstract][Full Text] [Related]
45. Comprehensive analysis of the prognostic value and immune function of chemokine-CXC receptor family members in breast cancer.
Lyu L; Zheng Y; Hong Y; Wang M; Deng Y; Wu Y; Xu P; Yang S; Wang S; Yao J; Zhang D; Guo Y; Lyu J; Dai Z
Int Immunopharmacol; 2020 Oct; 87():106797. PubMed ID: 32702599
[TBL] [Abstract][Full Text] [Related]
46. Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway.
Wang X; Zhang J; Zhou L; Sun W; Zheng ZG; Lu P; Gao Y; Yang XS; Zhang ZC; Tao KS; Dou KF
Int J Oncol; 2015 Jul; 47(1):231-43. PubMed ID: 25955618
[TBL] [Abstract][Full Text] [Related]
47. Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis.
Liu P; Wang X; Pan L; Han B; He Z
Front Immunol; 2022; 13():901784. PubMed ID: 35720327
[TBL] [Abstract][Full Text] [Related]
48. The FBXL family of F-box proteins: variations on a theme.
Mason B; Laman H
Open Biol; 2020 Nov; 10(11):200319. PubMed ID: 33234069
[TBL] [Abstract][Full Text] [Related]
49. Molecular dynamics simulations elucidate the mode of protein recognition by Skp1 and the F-box domain in the SCF complex.
Chandra Dantu S; Nathubhai Kachariya N; Kumar A
Proteins; 2016 Jan; 84(1):159-71. PubMed ID: 26573739
[TBL] [Abstract][Full Text] [Related]
50. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
[TBL] [Abstract][Full Text] [Related]
51. PLAGL1 (ZAC1/LOT1) Expression in Clear Cell Renal Cell Carcinoma: Correlations with Disease Progression and Unfavorable Prognosis.
Godlewski J; Krazinski BE; Kowalczyk AE; Kiewisz J; Kiezun J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Maslowski Z; Kmiec Z
Anticancer Res; 2016 Feb; 36(2):617-24. PubMed ID: 26851016
[TBL] [Abstract][Full Text] [Related]
52. Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes.
Yu JC; Ding SL; Chang CH; Kuo SH; Chen ST; Hsu GC; Hsu HM; Hou MF; Jung LY; Cheng CW; Wu PE; Shen CY
Carcinogenesis; 2009 Sep; 30(9):1562-70. PubMed ID: 19587092
[TBL] [Abstract][Full Text] [Related]
53. The Biology of F-box Proteins: The SCF Family of E3 Ubiquitin Ligases.
Nguyen KM; Busino L
Adv Exp Med Biol; 2020; 1217():111-122. PubMed ID: 31898225
[TBL] [Abstract][Full Text] [Related]
54. Roles of F-box proteins in cancer.
Wang Z; Liu P; Inuzuka H; Wei W
Nat Rev Cancer; 2014 Apr; 14(4):233-47. PubMed ID: 24658274
[TBL] [Abstract][Full Text] [Related]
55. Targeting SCF E3 Ligases for Cancer Therapies.
Liu J; Peng Y; Zhang J; Long J; Liu J; Wei W
Adv Exp Med Biol; 2020; 1217():123-146. PubMed ID: 31898226
[TBL] [Abstract][Full Text] [Related]
56. Significance of skp2 expression in primary breast cancer.
Sonoda H; Inoue H; Ogawa K; Utsunomiya T; Masuda TA; Mori M
Clin Cancer Res; 2006 Feb; 12(4):1215-20. PubMed ID: 16489076
[TBL] [Abstract][Full Text] [Related]
57. F-box protein interactions with the hallmark pathways in cancer.
Randle SJ; Laman H
Semin Cancer Biol; 2016 Feb; 36():3-17. PubMed ID: 26416465
[TBL] [Abstract][Full Text] [Related]
58. Skp2 Regulates the Expression of MMP-2 and MMP-9, and Enhances the Invasion Potential of Oral Squamous Cell Carcinoma.
Yamada S; Yanamoto S; Naruse T; Matsushita Y; Takahashi H; Umeda M; Nemoto TK; Kurita H
Pathol Oncol Res; 2016 Jul; 22(3):625-32. PubMed ID: 26874697
[TBL] [Abstract][Full Text] [Related]
59. Skp2 is oncogenic and overexpressed in human cancers.
Gstaiger M; Jordan R; Lim M; Catzavelos C; Mestan J; Slingerland J; Krek W
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5043-8. PubMed ID: 11309491
[TBL] [Abstract][Full Text] [Related]
60. Cdc53 is a scaffold protein for multiple Cdc34/Skp1/F-box proteincomplexes that regulate cell division and methionine biosynthesis in yeast.
Patton EE; Willems AR; Sa D; Kuras L; Thomas D; Craig KL; Tyers M
Genes Dev; 1998 Mar; 12(5):692-705. PubMed ID: 9499404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
